<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The case is described of a pregnant patient with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> scheduled at 39 weeks' gestation for elective caesarean section carried out for the first time by total intravenous anaesthesia (TIVA) with continuous intravenous (i.v.) infusion of <z:chebi fb="3" ids="44915">propofol</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnosis was based on a positive family history, classic phenotype, <z:hpo ids='HP_0002650'>scoliosis</z:hpo>, <z:hpo ids='HP_0001166'>arachnodactyly</z:hpo>, <z:hpo ids='HP_0000156'>high narrow palate</z:hpo>, <z:hpo ids='HP_0001382'>hyperextensible joints</z:hpo>, <z:hpo ids='HP_0001083'>ectopia lentis</z:hpo> and <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo>, with a secondary low <z:hpo ids='HP_0001653'>mitral insufficiency</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Maternal and fetal surveillance did not detect complications during the course of pregnancy </plain></SENT>
<SENT sid="3" pm="."><plain>Elective caesarean section was performed at 39 weeks due to <z:e sem="disease" ids="C0242786" disease_type="Disease or Syndrome" abbrv="">high-risk pregnancy</z:e> and to avoid the risk of haemodynamic alterations that take place during labour and delivery </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was given general anaesthesia with continuous i.v. infusion of <z:chebi fb="3" ids="44915">propofol</z:chebi> and boluses of atracurium and fentanyl after delivery </plain></SENT>
<SENT sid="5" pm="."><plain>The haemodynamics and oxygen saturation remained stable during surgery </plain></SENT>
<SENT sid="6" pm="."><plain>Apgar scores were 9 at 1 and 5 min </plain></SENT>
<SENT sid="7" pm="."><plain>The post-delivery course was unremarkable and post partum echocardiography showed no changes from before caesarean section </plain></SENT>
<SENT sid="8" pm="."><plain>The cardiovascular problems of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e>, the risk of haemodynamic changes associated with pregnancy and delivery, its <z:chebi fb="164" ids="38867">anaesthetic</z:chebi> implications and the possible advantages of TIVA with continuous i.v. infusion of <z:chebi fb="3" ids="44915">propofol</z:chebi> in the <z:chebi fb="164" ids="38867">anaesthetic</z:chebi> management of caesarean section in patients with this disease are discussed </plain></SENT>
</text></document>